Core Laboratories NV (CLB)

Return on total capital

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024
Earnings before interest and tax (EBIT) (ttm)	US$ in thousands	57,803	49,671	44,836	47,809
Long-term debt	US$ in thousands	126,111	139,872	147,621	160,370
Total stockholders’ equity	US$ in thousands	251,991	250,742	240,274	232,155
Return on total capital		15.29%	12.72%	11.56%	12.18%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $57,803K ÷ ($126,111K + $251,991K)
= 15.29%

Core Laboratories NV's return on total capital has shown a positive trend over the period from March 31, 2024, to December 31, 2024. The return on total capital increased from 12.18% in March to 15.29% in December. This indicates that the company is generating a higher return relative to the total capital employed in its operations. A rising return on total capital is generally a positive sign, suggesting that the company is utilizing its capital more efficiently and effectively to generate profits. This upward trend suggests that Core Laboratories NV's management is effectively utilizing the company's resources to drive profitability and create value for its stakeholders.